Bloomberg
Eli Lilly Antibody Drug Will Reduce Hospitalizations: CEO
Nov.10 -- Eli Lilly & Co. Chairman and Chief Executive Officer David Ricks discusses the drugmaker's Covid-19 antibody therapy bamlanivimab, which was recently granted an emergency-use authorization by the U.S. Food and Drug...
Bloomberg
AstraZeneca CEO on Vaccine Unit, Covid Endemic Stage
AstraZeneca CEO Pascal Soriot discusses expectations for sales and profit growth this year, plans for the company's vaccine unit, and seeing many countries moving to the endemic stage of the coronavirus pandemic. He speaks on "Bloomberg...
Curated Video
Can You Get The 'Antibody Cocktail' The President Got For COVID?
Coronavirus "antibody cocktails" are experimental right now, and typically only patients participating in a clinical trial can get them.
Bloomberg
The Realities of Vaccine Development
Oct.14 -- FDA Commissioner Stephen Hahn today telling Bloomberg that the halt in Eli Lilly's antibody trial, and other vaccine trials, is all about the process and safety. And should not be about politics. Dr. Jeremy Faust, emergency...
Curated Video
A Lab-Created Antibody Could Be First To Beat COVID-19
Researchers say the antibody, called 47D11, neutralized and killed the coronavirus in a lab setting.
Curated Video
A Lab-Created Antibody Could Be First To Beat COVID-19
Researchers say the antibody, called 47D11, neutralized and killed the coronavirus in a lab setting.
Curated Video
Eli Lilly Pauses Vaccine Trial
Pharmaceutical firm Eli Lilly's Phase 3 trial of a monoclonal antibody treatment was put on hold Tuesday.
Bloomberg
China's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies
May.12 -- Sheng Yao, co-founder and senior vice president of Shanghai Junshi Biosciences Co., talks about the company's agreement with Eli Lilly & Co. to co-develop therapeutic antibodies for the potential prevention and treatment of...
Curated Video
Antibody Treatments Boosted By President Trump Are Going Unused
Monoclonal antibody drugs like Regeneron's cocktail, could help fight the virus, but thousands of doses haven't been touched.
Curated Video
Spain Allows Rapid Antibody Test In Pharmacies
Spain will start offering rapid COVID-19 antibody tests in pharmacies.
Bloomberg
Sorrento's Covid-19 Antibody in Question
May.22 -- Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento...
Curated Video
Moderna's COVID-19 Vaccine Candidate To Enter Phase 3 Trial
Moderna says it will begin the next stage of its trial with 30,000 participants on July 27.
Bloomberg
Eli Lilly Covid Antibody Drug Cost Based on Nation's Wealth, Says CEO
Oct.07 -- Eli Lilly & Co. Chairman and Chief Executive Officer Dave Ricks discusses the pharmaceutical giant's approach to the U.S. Food and Drug Administration to authorize emergency use of its experimental Covid-19 antibody therapy, ....
Curated Video
Analyst: Antibodies don't always mean virus immunity
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
Bloomberg
Centivax Antibodies Aim to Combat Covid-19 Variants: CEO
Jan.25 -- Centivax CEO Jacob Glanville discusses the company’s antibody treatment for Covid-19 with the goal of making the pandemic a “manageable infectious disease.” He speaks with Bloomberg’s David Westin on "Bloomberg Markets:...
Bloomberg
Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Bloomberg
Glaxo Antibody Works Against Omicron Variant
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant. Sam Fazeli of Bloomberg Intelligence discusses the findings.
Curated Video
FDA Authorizes COVID Antibody Treatment For Post-Exposure Prevention
The agency authorized the treatment for those who are unvaccinated or are immunocompromised and have been exposed to someone who tested positive.
Curated Video
Analyst: Antibodies don't always mean virus immunity
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
Bloomberg
Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance
Nov.09 -- Pfizer Inc. and BioNTech SE are reporting positive results from their covid-19 vaccine trials, signaling a major breakthrough in the fight to contain the worst outbreak in a century. Meanwhile, Eli Lilly & Co.'s covid-19...
Bloomberg
Moderna Says New Vaccine Protects Against Two Covid Strains
Jan.25 -- Moderna Inc. said its vaccine will protect against two known variants of the Covid-19 vaccine, but it plans to start human studies of a booster shot for a strain from South Africa that may cause immunity to wane more quickly....
Bloomberg
Vaccine Development Process Can Be Safely Accelerated: Johns Hopkins
Oct.15 -- Johns Hopkins International Vaccine Access Center Executive Director William Moss discusses ways to safely accelerate the coronavirus vaccine development process, challenges in delivering a vaccine to patients, and the...
Press Association
Interview with Professor Roberts encourages plasma donations
Interview with Professor David Roberts on new plasma trials for the NHS to help fight coronavirus, as they call for more volunteers to come forward to donate.
Bloomberg
Covid-19 Vaccine Designed to Prevent Disease, Says Moderna CEO
Jun.15 -- Stephane Bancel, chief executive officer of Moderna, Inc., talks about the clinical trials they are running to develop a Covid-19 vaccine. He appears on "Leadership Live With David Rubenstein."